References
- Coronaviruses, Including SARS and MERS | Red Book® 2018 | Red Book Online | AAP Point-of-Care-Solutions. [cited 2020 May 18]. Available from: https://redbook.solutions.aap.org/chapter.aspx?sectionid=189640073&bookid=2205.
- Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)). Clin Exp Pediatr. 2020;63(4):119–124.
- Coronavirus (COVID-19) events as they happen. [cited 2020 May 18]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
- COVID-19 Map - Johns Hopkins Coronavirus Resource Center. [cited 2020 Apr 23]. Available from: https://coronavirus.jhu.edu/map.html.
- Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251.
- van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567.
- Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should face the reality. Environ Int. 2020;139:105730.
- Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. Published online March 26, 2020:2000547. doi:10.1183/13993003.00547-2020
- Richardson S, Hirsch JS, Narasimhan M, and the Northwell COVID-19 Research Consortium, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72–314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242.
- Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: The reality and challenges. J Microbiol Immunol Infect. 2020;53(3):436-443.
- Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020;382(19):1787–1799.
- Geleris J, Sun Y, Platt J, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med. 2020;382(25):2411–2418.
- NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 | NIH: National Institute of Allergy and Infectious Diseases. [cited 2020 May 19]. Available from: https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19.
- Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):eabb5793.
- Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for diagnosis and prognosis of covid-19 infection: Systematic review and critical appraisal. BMJ. 2020;369:m1328.
- Yan L, Zhang H-T, Goncalves J, et al. An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell. 2020;2(5):283–286.
- About Us | Beaumont Health. [cited 2020 May 14]. Available from: https://www.beaumont.org/about-us.
- Clinical management of severe acute respiratory infection when COVID-19 is suspected. [cited 2020 Apr 23]. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-. (ncov)-infection-is-suspected.
- Software | Epic. [cited 2020 May 14]. Available from: https://www.epic.com/software.
- All of US News’ top 20 hospitals use Epic. [cited 2020 May 14]. Available from: https://www.beckershospitalreview.com/ehrs/all-of-us-news-top-20-hospitals-use-epic.html.
- Information for Healthcare Professionals: COVID-19 and Underlying Conditions | CDC. [cited 2020 May 17]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/underlying-conditions.html.
- Hosmer DW, Jr, Lemeshow S. Applied logistic regression. 2nd ed. New York; Wiley, 2000.
- Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med. 2014;33(3):517–535.
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). [cited 2020 May 18]. Available from: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19. ).
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Ewig S, Bauer T, Richter K, et al. Prediction of in-hospital death from community-acquired pneumonia by varying crb-age groups. Eur Respir J. 2013;41(4):917–922.
- Cher EWL, Allen JC, Howe T, et al. Comorbidity as the dominant predictor of mortality after hip fracture surgeries. Osteoporos Int. 2019;30(12):2477–2483.
- Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit Care. 2020;24(1):108.
- Yong EL, Ganesan G, Kramer MS, et al. Risk factors and trends associated with mortality among adults with hip fracture in Singapore. JAMA Netw Open. 2020;3(2):e1919706.
- Caramelo F, Ferreira N, Oliveiros B. Estimation of risk factors for COVID-19 mortality - preliminary results. medRxiv. 2020;19:2020.02.24.20027268.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
- DeCaprio D, Gartner JA, Burgess T, et al. Building a COVID-19 Vulnerability Index. medRxiv. 2020;2020:03–16.
- Xie J, Hungerford D, Chen H, et al. Development and external validation of a prognostic multivariable model on admission for hospitalized patients with COVID-19. medRxiv. Published online April 7, 2020:2020.03.28.20045997.
- Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among medicare beneficiaries hospitalized for heart failure. JAMA - J Am Med Assoc. 2010;303(17):1716–1722.
- Tong L, Arnold T, Yang J, et al. The association between outpatient follow-up visits and all-cause non-elective 30-day readmissions: a retrospective observational cohort study. PLoS One. 2018;13(7):e0200691.
- Rao BB, Sobotka A, Lopez R, et al. Outpatient telephonic transitional care after hospital discharge improves survival in cirrhotic patients. World J Hepatol. 2019;11(8):646–655.
- Restrepo MI, Faverio P, Anzueto A. Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis. 2013;26(2):151–158.
- Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.